Dexmedetomidine and Agitation After Nasal Surgery

Recruiting N/A Interventional Study
Nasal Disease Agitation, Emergence
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
50 (estimated)
Sponsor
Fayoum University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologist (ASA) Ⅰ or II * Adults with body mass index (BMI) \< 30 Kg/m * Underwent elective nasal surgery. Exclusion Criteria: * Significant comorbidity like hepatic, renal, or cardiac disease * Auditory impairment * Cognitive dysfunction * Substan…
Contacts

Yasser S Mostafa, MD

01010509735

ysm03@fayoum.edu.eg

CONTACT

Mohamed A Shawky, MD

0 109 525 4547

mas14@fayoum.edu.eg

CONTACT